These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 20058682

  • 1. [Efficacy of fluoro-2-deoxyglucose positron emission tomography imaging in response evaluation of patients with small cell lung cancer (pilot study)].
    Isobe K, Kaburaki K, Sakaguchi S, Takai Y, Hata Y, Homma S.
    Nihon Kokyuki Gakkai Zasshi; 2009 Dec; 47(12):1077-81. PubMed ID: 20058682
    [Abstract] [Full Text] [Related]

  • 2. Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
    Skougaard K, Nielsen D, Jensen BV, Hendel HW.
    J Nucl Med; 2013 Jul; 54(7):1026-31. PubMed ID: 23572497
    [Abstract] [Full Text] [Related]

  • 3. Therapy response evaluation with FDG-PET/CT in small cell lung cancer: a prognostic and comparison study of the PERCIST and EORTC criteria.
    Ziai D, Wagner T, El Badaoui A, Hitzel A, Woillard JB, Melloni B, Monteil J.
    Cancer Imaging; 2013 Mar 05; 13(1):73-80. PubMed ID: 23466871
    [Abstract] [Full Text] [Related]

  • 4. High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer.
    Lee YJ, Cho A, Cho BC, Yun M, Kim SK, Chang J, Moon JW, Park IK, Choi HJ, Kim JH.
    Clin Cancer Res; 2009 Apr 01; 15(7):2426-32. PubMed ID: 19318478
    [Abstract] [Full Text] [Related]

  • 5. [Clinical significance of (18)F-FDG PET-CT in evaluation of the therapeutic efficacy of chemotherapy for lung cancer].
    Jia P, Guo WH, Zhang Y.
    Zhonghua Zhong Liu Za Zhi; 2009 Mar 01; 31(3):235-6. PubMed ID: 19615270
    [No Abstract] [Full Text] [Related]

  • 6. Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure.
    Mac Manus MP, Hicks RJ, Matthews JP, Wirth A, Rischin D, Ball DL.
    Lung Cancer; 2005 Jul 01; 49(1):95-108. PubMed ID: 15949595
    [Abstract] [Full Text] [Related]

  • 7. Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study.
    van Loon J, De Ruysscher D, Wanders R, Boersma L, Simons J, Oellers M, Dingemans AM, Hochstenbag M, Bootsma G, Geraedts W, Pitz C, Teule J, Rhami A, Thimister W, Snoep G, Dehing-Oberije C, Lambin P.
    Int J Radiat Oncol Biol Phys; 2010 Jun 01; 77(2):329-36. PubMed ID: 19782478
    [Abstract] [Full Text] [Related]

  • 8. Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET).
    Kut V, Spies W, Spies S, Gooding W, Argiris A.
    Am J Clin Oncol; 2007 Feb 01; 30(1):45-50. PubMed ID: 17278894
    [Abstract] [Full Text] [Related]

  • 9. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.
    Interact Cardiovasc Thorac Surg; 2010 Jun 01; 10(6):1009-14. PubMed ID: 20197344
    [Abstract] [Full Text] [Related]

  • 10. Early assessment of therapeutic response using FDG PET in small cell lung cancer.
    Yamamoto Y, Kameyama R, Murota M, Bandoh S, Ishii T, Nishiyama Y.
    Mol Imaging Biol; 2009 Jun 01; 11(6):467-72. PubMed ID: 19434460
    [Abstract] [Full Text] [Related]

  • 11. Early prediction of response to first-line therapy using integrated 18F-FDG PET/CT for patients with advanced/metastatic non-small cell lung cancer.
    Lee DH, Kim SK, Lee HY, Lee SY, Park SH, Kim HY, Kang KW, Han JY, Kim HT, Lee JS.
    J Thorac Oncol; 2009 Jul 01; 4(7):816-21. PubMed ID: 19487962
    [Abstract] [Full Text] [Related]

  • 12. Is (18)F-FDG-PET/CT prognostic factor for survival in patients with small cell lung cancer? Single center experience.
    Inal A, Kucukoner M, Kaplan MA, Urakci Z, Nas N, Guven M, Dostbil Z, Altindag S, Isikdogan A.
    Rev Port Pneumol; 2013 Jul 01; 19(6):260-5. PubMed ID: 23993406
    [Abstract] [Full Text] [Related]

  • 13. Detection of an asymptomatic right-ventricle cardiac metastasis from a small-cell lung cancer by F-18-FDG PET/CT.
    Orcurto MV, Delaloye AB, Letovanec I, Martins Favre M, Prior JO.
    J Thorac Oncol; 2009 Jan 01; 4(1):127-30. PubMed ID: 19096320
    [Abstract] [Full Text] [Related]

  • 14. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Deniaud-Alexandre E, Touboul E, Lerouge D, Grahek D, Foulquier JN, Petegnief Y, Grès B, El Balaa H, Keraudy K, Kerrou K, Montravers F, Milleron B, Lebeau B, Talbot JN.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1432-41. PubMed ID: 16125870
    [Abstract] [Full Text] [Related]

  • 15. Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer.
    Hoekstra CJ, Stroobants SG, Smit EF, Vansteenkiste J, van Tinteren H, Postmus PE, Golding RP, Biesma B, Schramel FJ, van Zandwijk N, Lammertsma AA, Hoekstra OS.
    J Clin Oncol; 2005 Nov 20; 23(33):8362-70. PubMed ID: 16293866
    [Abstract] [Full Text] [Related]

  • 16. The role of positron emission tomography in management of small cell lung cancer.
    Thomson D, Hulse P, Lorigan P, Faivre-Finn C.
    Lung Cancer; 2011 Aug 20; 73(2):121-6. PubMed ID: 21524814
    [Abstract] [Full Text] [Related]

  • 17. 18F-fluorodeoxyglucose positron emission tomography in small-cell lung cancer.
    Zhao DS, Valdivia AY, Li Y, Blaufox MD.
    Semin Nucl Med; 2002 Oct 20; 32(4):272-5. PubMed ID: 12524651
    [Abstract] [Full Text] [Related]

  • 18. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.
    Frank A, Lefkowitz D, Jaeger S, Gobar L, Sunderland J, Gupta N, Scott W, Mailliard J, Lynch H, Bishop J.
    Int J Radiat Oncol Biol Phys; 1995 Jul 30; 32(5):1495-512. PubMed ID: 7635795
    [Abstract] [Full Text] [Related]

  • 19. PET/CT imaging in response evaluation of patients with small cell lung cancer.
    Fischer BM, Mortensen J, Langer SW, Loft A, Berthelsen AK, Daugaard G, Lassen U, Hansen HH.
    Lung Cancer; 2006 Oct 30; 54(1):41-9. PubMed ID: 16919841
    [Abstract] [Full Text] [Related]

  • 20. Value of combined interpretation of computed tomography response and positron emission tomography response for prediction of prognosis after neoadjuvant chemotherapy in non-small cell lung cancer.
    Lee HY, Lee HJ, Kim YT, Kang CH, Jang BG, Chung DH, Goo JM, Park CM, Lee CH, Kang KW.
    J Thorac Oncol; 2010 Apr 30; 5(4):497-503. PubMed ID: 20195167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.